CSSB Centre for Structural Systems Biology, Hamburg, Germany; Department of Cellular Parasitology, Bernhard Nocht Institute for Tropical Medicine, Hamburg, Germany; Department of Biology, University of Hamburg, Hamburg, Germany.
CSSB Centre for Structural Systems Biology, Hamburg, Germany; Hamburg Unit, European Molecular Biology Laboratory, Hamburg, Germany.
J Biol Chem. 2022 Sep;298(9):102360. doi: 10.1016/j.jbc.2022.102360. Epub 2022 Aug 10.
Malaria is responsible for hundreds of thousands of deaths every year. The lack of an effective vaccine and the global spread of multidrug resistant parasites hampers the fight against the disease and underlines the need for new antimalarial drugs. Central to the pathogenesis of malaria is the proliferation of Plasmodium parasites within human erythrocytes. Parasites invade erythrocytes via a coordinated sequence of receptor-ligand interactions between the parasite and the host cell. Posttranslational modifications such as protein phosphorylation are known to be key regulators in this process and are mediated by protein kinases. For several parasite kinases, including the Plasmodium falciparum glycogen synthase kinase 3 (PfGSK3), inhibitors have been shown to block erythrocyte invasion. Here, we provide an assessment of PfGSK3 function by reverse genetics. Using targeted gene disruption, we show the active gene copy, PfGSK3β, is not essential for asexual blood stage proliferation, although it modulates efficient erythrocyte invasion. We found functional inactivation leads to a 69% decreased growth rate and confirmed this growth defect by rescue experiments with wildtype and catalytically inactive mutants. Functional knockout of PfGSK3β does not lead to transcriptional upregulation of the second copy of PfGSK3. We further analyze expression, localization, and function of PfGSK3β during gametocytogenesis using a parasite line allowing conditional induction of sexual commitment. We demonstrate PfGSK3β-deficient gametocytes show a strikingly malformed morphology leading to the death of parasites in later stages of gametocyte development. Taken together, these findings are important for our understanding and the development of PfGSK3 as an antimalarial target.
疟疾每年导致数十万人死亡。缺乏有效的疫苗和多药耐药寄生虫在全球的传播阻碍了对该疾病的防治工作,并突显了开发新抗疟药物的必要性。疟原虫在人体红细胞内的增殖是疟疾发病机制的核心。寄生虫通过寄生虫和宿主细胞之间的一系列协调受体-配体相互作用入侵红细胞。蛋白质磷酸化等翻译后修饰被认为是该过程的关键调节剂,由蛋白激酶介导。对于包括恶性疟原虫糖原合酶激酶 3(PfGSK3)在内的几种寄生虫激酶,已经证明抑制剂可以阻断红细胞入侵。在这里,我们通过反向遗传学评估 PfGSK3 的功能。通过靶向基因敲除,我们表明活性基因拷贝 PfGSK3β 对于无性血期增殖不是必需的,尽管它调节有效的红细胞入侵。我们发现功能失活导致生长速率降低 69%,并通过野生型和催化失活突变体的挽救实验证实了这一生长缺陷。PfGSK3β 的功能敲除不会导致 PfGSK3 的第二个拷贝的转录上调。我们进一步在允许有性转化条件诱导的寄生虫系中分析 PfGSK3β 在配子体发生过程中的表达、定位和功能。我们证明 PfGSK3β 缺陷型配子体表现出明显的畸形形态,导致寄生虫在配子体发育的后期死亡。总之,这些发现对于我们理解 PfGSK3 作为抗疟靶点的作用以及开发它具有重要意义。